Dr. Martens PLC (DOCS) - Cash Flow Conversion Efficiency

Latest as of September 2025: -0.049x

Based on the latest financial reports, Dr. Martens PLC (DOCS) has a cash flow conversion efficiency ratio of -0.049x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-16.10 Million ≈ $-1.96K USD) by net assets (GBX329.10 Million ≈ $40.04K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Dr. Martens PLC - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Dr. Martens PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read DOCS current and long-term liabilities for a breakdown of total debt and financial obligations.

Dr. Martens PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Dr. Martens PLC ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Sintex Plastics Technology Limited NSE:SPTL	-11.870x
Morgan Advanced Materials plc LSE:MGAM	0.133x
Raj Oil Mills Limited NSE:ROML	1.915x
Digitree Group S.A WAR:DTR	0.160x
Anmol India Limited NSE:ANMOL	0.002x
FUTURE METALS NL F:3R10	N/A
Dhruv Consultancy Services Limited NSE:DHRUV	0.024x
Koba Resources Ltd AU:KOB	N/A

Annual Cash Flow Conversion Efficiency for Dr. Martens PLC (2014–2025)

The table below shows the annual cash flow conversion efficiency of Dr. Martens PLC from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Dr. Martens PLC market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	GBX366.40 Million ≈ $44.58K	GBX196.30 Million ≈ $23.88K	0.536x	+17.49%
2024-03-31	GBX368.20 Million ≈ $44.80K	GBX167.90 Million ≈ $20.43K	0.456x	+138.44%
2023-03-31	GBX404.20 Million ≈ $49.18K	GBX77.30 Million ≈ $9.41K	0.191x	-65.96%
2022-03-31	GBX328.20 Million ≈ $39.93K	GBX184.40 Million ≈ $22.44K	0.562x	-30.25%
2021-03-31	GBX150.70 Million ≈ $18.34K	GBX121.40 Million ≈ $14.77K	0.806x	-53.22%
2020-03-31	GBX70.50 Million ≈ $8.58K	GBX121.40 Million ≈ $14.77K	1.722x	+125.83%
2019-03-31	GBX-8.40 Million ≈ $-1.02K	GBX56.00 Million ≈ $6.81K	-6.667x	-326.09%
2018-03-31	GBX-29.40 Million ≈ $-3.58K	GBX46.00 Million ≈ $5.60K	-1.565x	+18.13%
2017-03-31	GBX-18.00 Million ≈ $-2.19K	GBX34.40 Million ≈ $4.19K	-1.911x	+18.52%
2016-03-31	GBX-11.00 Million ≈ $-1.34K	GBX25.80 Million ≈ $3.14K	-2.345x	-109.48%
2015-03-31	GBX800.00K ≈ $97.34	GBX19.80 Million ≈ $2.41K	24.750x	+643.39%
2014-03-31	GBX1.51 Million ≈ $183.60	GBX5.02 Million ≈ $611.28	3.329x	--

About Dr. Martens PLC

LSE:DOCS UK Footwear & Accessories

Market Cap

$7.29 Million

GBX59.93 Billion GBX

Market Cap Rank

#27585 Global

#399 in UK

Share Price

GBX62.00

Change (1 day)

-0.32%

52-Week Range

GBX54.70 - GBX99.35

All Time High

GBX470.02